Lung cancer classification: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 129: | Line 129: | ||
===Metastatic Tumors=== | ===Metastatic Tumors=== | ||
==TNM Classification of Carcinomas of the Lung== | |||
===T: Primary Tumor=== | |||
{| | |||
|TX || Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy | |||
|- | |||
| T0 ||No evidence of primary tumor | |||
|- | |||
|Tis ||Carcinoma in situ | |||
|- | |||
|T1 ||tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus, i.e., not in the main bronchus | |||
|- | |||
|T2 ||tumor with any of the following features of size or extent: | |||
• More than 3 cm in greatest dimension | |||
<br> OR <br> | |||
• Involves main bronchus, 2 cm or more distal to the carina | |||
<br> OR <br> | |||
• Invades visceral pleura | |||
<br> OR <br> | |||
• Associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung | |||
|- | |||
|T3 ||tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium<br> OR <br>tumor in the main bronchus less than 2 cm distal to the carina1 but without involvement of the carina<br> OR <br>associated atelectasis or obstructive pneumonitis of the entire lung | |||
|- | |||
|T4 ||tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, oesophagus, vertebral body, carina<br> OR <br>separate tumor nodule(s) in the same lobe <br> OR <br>tumor with malignant pleural effusion. | |||
|} | |||
===M: Distant Metastasis=== | |||
==References== | ==References== | ||
Revision as of 16:08, 9 June 2014
|
Lung cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lung cancer classification On the Web |
|
American Roentgen Ray Society Images of Lung cancer classification |
|
Risk calculators and risk factors for Lung cancer classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Kim-Son H. Nguyen, M.D., M.P.A., Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA, Cafer Zorkun, M.D., Ph.D. [2]
Overview
Primary lung cancer can be classified into two main categories: small cell lung cancer (~15%) and non small cell lung cancer (~85%). Non small cell lung cancer includes several subtypes classified by their histopathological findings, and they are grouped together because their prognosis and management are similar. The 2004 WHO histological classification of tumors of the lung categorized lung tumors into malignant epithelial tumors, benign epithelial tumors, lymphoproliferative tumors, miscellaneous tumors, and metastatic tumors.[1]
Classification
- Primary lung cancer can be classified into two main categories: small cell lung cancer (~15%) and non small cell lung cancer (~85%).
- There are three main sub-types of non small cell lung cancer , which are grouped together because their prognosis and management are similar:
- Squamous cell carcinoma (25% of lung cancers)
- Adenocarcinoma (40% of lung cancers) and large cell lung carcinoma (10% of lung cancers)
- Large cell carcinoma (10% of lung cancers)
- A subtype of adenocarcinoma, the bronchioloalveolar carcinoma, is more common in female never-smokers, and may have different responses to treatment.[2]
WHO Histological Classification of Tumors of the Lung [1]
Malignant Epithelial Tumors
- Squamous cell carcinoma
- Papillary
- Clear cell
- Small cell
- Basaloid
- Small cell carcinoma
- Combined small cell carcinoma
- Adenocarcinoma
- Adenocarcinoma, mixed subtype
- Acinar adenocarcinoma
- Papillary adenocarcinoma
- Bronchioloalveolar carcinoma
- Nonmucinous
- Mucinous
- Mixed nonmucinous and mucinous or indeterminate
- Solid adenocarcinoma with mucin production
- Fetal adenocarcinoma
- Mucinous (“colloid”) carcinoma
- Mucinous cystadenocarcinoma
- Signet ring adenocarcinoma
- Clear cell adenocarcinoma
- Large cell carcinoma
- Large cell neuroendocrine carcinoma
- Combined large cell neuroendocrine carcinoma
- Basaloid carcinoma
- Lymphoepithelioma-like carcinoma
- Clear cell carcinoma
- Large cell carcinoma with rhabdoid phenotype
- Adenosquamous carcinoma
- Sarcomatoid carcinoma
- Pleomorphic carcinoma
- Spindle cell carcinoma
- Giant cell carcinoma
- Carcinosarcoma
- Pulmonary blastoma
- Carcinoid tumor
- Typical carcinoid
- Atypical carcinoid
- Salivary gland tumors
- Mucoepidermoid carcinoma
- Adenoid cystic carcinoma
- Epithelial-myoepithelial carcinoma
- Preinvasive lesions
- Squamous carcinoma in situ
- Atypical adenomatous hyperplasia
- Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
- Mesenchymal tumors
- Epithelioid haemangioendothelioma
- Angiosarcoma
- Pleuropulmonary blastoma
- Chondroma
- Congenial peribronchial myofibroblastic tumor
- Diffuse pulmonary lymphangiomatosis
- Inflammatory myofibroblastic tumor
- Lymphangioleiomyomatosis
- Synovial sarcoma
- Monophasic
- Biphasic
- Pulmonary artery sarcoma
- Pulmonary vein sarcoma
Benign Epithelial Tumors
- Papillomas
- Squamous cell papilloma
- Exophytic
- Inverted
- Glandular papilloma
- Mixed squamous cell and glandular papilloma
- Adenomas
- Alveolar adenoma
- Papillary adenoma
- Adenomas of the salivary gland type
- Mucous gland adenoma
- Pleomorphic adenoma
- Others
- Mucinous cystadenoma
Lymphoproliferative Tumors
- Marginal zone B-cell lymphoma of the MALT type
- Diffuse large B-cell lymphoma
- Lymphomatoid granulomatosis
- Langerhans cell histiocytosis
Miscellaneous Tumors
- Harmatoma
- Sclerosing hemangioma
- Clear cell tumor
- Germ cell tumors
- Teratoma, mature
- Immature
- Other germ cell tumors
- Intrapulmonary thymoma
- Melanoma
Metastatic Tumors
TNM Classification of Carcinomas of the Lung
T: Primary Tumor
| TX | Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy |
| T0 | No evidence of primary tumor |
| Tis | Carcinoma in situ |
| T1 | tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus, i.e., not in the main bronchus |
| T2 | tumor with any of the following features of size or extent:
• More than 3 cm in greatest dimension
|
| T3 | tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium OR tumor in the main bronchus less than 2 cm distal to the carina1 but without involvement of the carina OR associated atelectasis or obstructive pneumonitis of the entire lung |
| T4 | tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, oesophagus, vertebral body, carina OR separate tumor nodule(s) in the same lobe OR tumor with malignant pleural effusion. |
M: Distant Metastasis
References
- ↑ 1.0 1.1 Travis, William (2004). Pathology and genetics of tumours of the lung, pleura, thymus, and heart. Lyon: IARC Press. ISBN 9283224183.
- ↑ Raz, DJ (Mar 2006). "Bronchioloalveolar carcinoma: a review". Clinical Lung Cancer. Cancer Information Group. 7 (5): 313–322. PMID 16640802. Unknown parameter
|coauthors=ignored (help)